Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leprêtre

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Reproduction (Oxford, England)|May 1, 1991
Ureaplasma in semen and IVFJ M Montagut, S Leprêtre, J Degoy, et al.
La Revue De Medecine Interne|March 25, 2014
[Spontaneous intrahepatic hematoma: an unexpected etiology]M Khetta, C Lemaître, V Lecam Duchez, et al.
Leukemia|September 23, 2006
Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markersF Jardin, S S Sahota, P Ruminy, et al.
International Journal of Pharmaceutics|September 7, 2010
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gelT H Hoang Thi, F Chai, S Leprêtre, et al.
Leukemia|October 26, 2002
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristicsF Jardin, P Gaulard, G Buchonnet, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 7, 2014
Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access programJ Dupuis, P Brice, S François, et al.
Leukemia|October 26, 2002
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangementsF Jardin, G Buchonnet, F Parmentier, et al.
Bone Marrow Transplantation|July 7, 2015
Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovirV Camus, J-P Bouwyn, A Chamseddine, et al.
Blood Cancer Journal|January 23, 2016
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groupsA-L Gagez, E Tuaillon, R Cezar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Reproduction (Oxford, England)|May 1, 1991
Ureaplasma in semen and IVFJ M Montagut, S Leprêtre, J Degoy, et al.
La Revue De Medecine Interne|March 25, 2014
[Spontaneous intrahepatic hematoma: an unexpected etiology]M Khetta, C Lemaître, V Lecam Duchez, et al.
Leukemia|September 23, 2006
Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markersF Jardin, S S Sahota, P Ruminy, et al.
International Journal of Pharmaceutics|September 7, 2010
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gelT H Hoang Thi, F Chai, S Leprêtre, et al.
Leukemia|October 26, 2002
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristicsF Jardin, P Gaulard, G Buchonnet, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 7, 2014
Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access programJ Dupuis, P Brice, S François, et al.
Leukemia|October 26, 2002
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangementsF Jardin, G Buchonnet, F Parmentier, et al.
Bone Marrow Transplantation|July 7, 2015
Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovirV Camus, J-P Bouwyn, A Chamseddine, et al.
Blood Cancer Journal|January 23, 2016
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groupsA-L Gagez, E Tuaillon, R Cezar, et al.
Pageof 1